Crinetics Pharmaceuticals, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.7 | $1.0 | $4.0 | $0.0 | $0.0 |
| Operating income | -$516.8 | -$338.9 | -$222.6 | -$167.9 | -$107.7 |
| Net income | -$465.3 | -$298.4 | -$214.5 | -$163.9 | -$107.6 |
| Cash Flow Statement | |||||
| Free cash flow | -$383.7 | -$234.0 | -$173.3 | -$116.9 | -$89.0 |
Shares outstanding 105.4M · Free float 90.6%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.